• Asunaprevir (BMS-650032): HCV NS3 Inhibitor

  2026-09-22

  Asunaprevir, also called BMS-650032, is an orally efficacious HCV NS3/4A protease inhibitor with a product-reported biochemical IC50 of 1 nM. Its research value comes from direct blockade of viral polyprotein processing, broad subtype activity, and hepatotropic disposition, while its IC50 values, vehicle solubility, and cell-based effects require assay-specific interpretation.

• Dasatinib Monohydrate in CML NET Assays

  2026-09-22

  Dasatinib Monohydrate (BMS-354825) supports integrated studies of BCR-ABL signaling, drug resistance, leukemic-cell survival, and neutrophil extracellular traps. This workflow translates CML NET biology into practical assay design, with controls for target engagement, compound handling, and TKI-specific inflammatory effects.

• ABT-199 (Venetoclax) Experimental Workflows

  2026-09-21

  ABT-199 (Venetoclax) provides a selective way to test BCL-2 dependence in apoptosis assays, non-Hodgkin lymphoma research, and acute myelogenous leukemia models. This workflow also shows how to translate the compound cautiously into exploratory studies of senescent, disease-associated microglia without confusing BCL-2-dependent cell killing with validated brain senolysis.

• Ibrutinib (PCI-32765): An Assay-First BTK Guide

  2026-09-21

  Explore how Ibrutinib (PCI-32765) can be used as a mechanistic perturbation tool for B-cell receptor signaling inhibition, chronic lymphocytic leukemia research, and autoimmune disease models. This assay-first guide also extracts practical design lessons from an independent amyloid study without overstating cross-domain evidence.

• HDAC Inhibitors Repress NUT Function in NUT Carcinoma

  2026-09-20

  Shiota et al. developed a dCas9-based high-throughput reporter screen that identified structurally diverse HDAC inhibitors as repressors of NUT-driven transcription. Panobinostat and IRBM6 reduced NUT carcinoma growth, promoted differentiation, and disrupted BRD4-NUT megadomain activity, providing a mechanistic rationale for HDAC-directed treatment strategies.

• Asunaprevir and the New Logic of Translational Screening

  2026-09-19

  Asunaprevir (BMS-650032) illustrates how HCV NS3 protease potency can be converted into a translational evidence chain spanning genotype breadth, HCV RNA replication inhibition, cellular selectivity, and liver-relevant exposure. By comparing this antiviral framework with mechanistic lessons from HDAC inhibition in NUT carcinoma, the article offers a disciplined strategy for moving from chemical screening to actionable biology without overstating cross-domain evidence.

• HDAC Inhibitors and NUT Carcinoma Pathogenesis

  2026-09-18

  Shiota et al. developed a dCas9-based high-throughput reporter screen that identified structurally diverse HDAC inhibitors as repressors of NUT-dependent transcription. Panobinostat and IRBM6 reduced megadomain-associated oncogenic programs, promoted differentiation, and suppressed NUT carcinoma growth, including in xenograft models.

• ARID1A-Dependent Resistance in Melanoma Multi-Omics

  2026-09-18

  The reference study integrates multi-omics and network analysis to show how ARID1A loss rewires early drug-response signaling in BRAF-mutant melanoma. Its identification of PRKD1, JUN, and NCK1 as resistance-associated nodes provides a mechanistic framework for studying MAPK inhibitor persistence, immune-evasion features, and therapeutic durability.

• Dasatinib Monohydrate in Gastric Cancer Assembloids

  2026-09-17

  Dasatinib Monohydrate offers a mechanistically interpretable way to study kinase-dependent drug response across matched gastric tumor organoids and stromal assembloids. This article translates recent patient-derived model findings into practical assay design, controls, and resistance-interpretation strategies.

• 2-NBDG and Sorafenib Resistance in HCC

  2026-09-17

  A translational framework for using fluorescent glucose uptake measurements to complement lipidomics, ferroptosis assays, and organoid models of sorafenib-resistant hepatocellular carcinoma.

• TUNEL Apoptosis Detection Kit: Fish Cell Workflow

  2026-09-16

  Learn how to use a DAB-based TUNEL assay to map DNA fragmentation in oxidative-stress experiments, cultured cells, and tissue sections. This workflow connects the reference study’s miR-183-5p/Keap1-Nrf2 mechanism with practical controls, brightfield imaging, and troubleshooting strategies.

• Anlotinib hydrochloride: Angiogenesis Workflow

  2026-09-16

  Build a mechanism-led angiogenesis workflow around Anlotinib hydrochloride, from receptor phosphorylation to migration and tube formation. The approach combines multi-target pathway validation with practical controls, dose selection, and troubleshooting for reproducible cancer research.

• DRB: A Temporal Probe of RNA Synthesis

  2026-09-15

  5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) is more than a transcriptional inhibitor: it is a practical temporal probe for separating RNA synthesis from downstream translation phenotypes. This article connects DRB assay design with new ac4C–lncRNA research while defining the compound’s mechanistic limits.

• Bleomycin Sulfate: From DNA Breaks to Translation

  2026-09-15

  Bleomycin Sulfate is more than a cytotoxic reagent: it is a controllable stress test for DNA damage response, repair capacity, and tissue injury. This article connects its metal-dependent DNA strand-breaking activity with ATM–homologous recombination biology, oncology model design, and pulmonary fibrosis research while outlining practical translational decision points.

• IL-23R as a Senescence-Linked Biomarker of Aging

  2026-09-14

  Carver and colleagues identified IL-23R as a circulating and tissue-associated marker that tracks age-related senescence and responds to senolytic intervention in mice. By comparing pharmacological senolytics with p16-InkAttac-mediated senescent-cell clearance and examining human plasma, the study provides a framework for evaluating systemic senescence biomarkers and possible interorgan signaling factors.

8152 records 1/544 page Next 12345 下5页 Last page